Deoxyspergualin: Mechanism of action and pharmacokinetics

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 873-875

  Ramos, E L ^a   Nadler, S G ^a   Grasela, D M ^a   Kelley, S L ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DRUG CLEARANCE; DRUG HALF LIFE; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, RHEUMATOID; CELL NUCLEUS; GUANIDINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NEOPLASMS; NF-KAPPA B; T-LYMPHOCYTES;

EID: 0029960987     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)